Business
Prota raises US$21M led by Singapore’s SPRIM for its peanut allergy therapy
Singapore-based health sciences VC firm SPRIM Global Investments has led the US$21 million funding round (equity and debt) of Australian biotech firm Prota Therapeutics. The fresh funding will be used to advance the development of Prota’s peanut alle
By: e27
- Jan 17 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLAN